Prednisone Acetate Tablets Application Scope

Prednisone Acetate Tablets are used for connective tissue disease, systemic lupus erythematosus, severe bronchial asthma, dermatomyositis, vasculitis and other allergic diseases, acute leukemia, malignant lymphoma, and for other adrenocorticotropic hormone analogs.

Characteristics of Prednisone Acetate Tablets

Ingredient: Prednisone Acetate

Characteristics: allergic and autoimmune inflammatory diseases

Specification: 5 mgPacking specification polyethylene bottle, 100 tablets per bottle; 1000 tablets per bottle; 2000 tablets per bottle.

Storage: Shielded from light and kept sealed.

Effective period: 36 months

Execution standard: Chinese Pharmacopoeia 2010 Edition II

Approval number: State Pharmacopoeia H33021207

Revision Date According to the latest drug instruction.

Manufacturer: Zhejiang Xianju Pharmaceutical Co.

Guidelines for the use of Prednisone Acetate Tablets

Dosage and administration: Oral usually 5-10mg (1-2 tablets) at one time, 10-60mg (2-12 tablets) a day. If necessary, discretionary increase or decrease, as determined by the doctor.

Adverse Reaction: Susceptible to diabetes mellitus, peptic ulcers and Cushing-like syndrome symptoms.

Strong inhibition of the hypothalamic-pituitary-adrenal axis. Complications.

Restrictions

Contraindications: Adrenocorticotropic hormones are contraindicated in patients with a history of hypersensitivity.

Precautions: 1. Use with caution in patients with tuberculosis, acute bacterial or viral infections. When necessary application, appropriate anti-infective treatment must be given.

2. After long-term medication, the dosage should be gradually reduced before stopping.

3. Use with caution in patients with diabetes mellitus, osteoporosis, cirrhosis, renal dysfunction, hypothyroidism.

4. For those with bacterial, fungal or viral infections, it should be used with caution while applying sufficient amount of sensitive antibiotics.

5. Use with caution in athletes.

Interaction of Prednisone Acetate Tablets

Prednisone Acetate Tablets and non-steroidal anti-inflammatory analgesic drugs can enhance their ulcerogenic effect. May enhance the hepatotoxicity of acetaminophen. Combined with amphotericin B or carbonic anhydrase inhibitors, can aggravate hypokalemia, long-term combined with carbonic anhydrase inhibitors, prone to hypokalemia and osteoporosis.

Note: If there is a new packaging for the drug, the new packaging shall prevail. The above information is sourced from DengYueMed. It is only for internal discussion among medical staff and does not serve as a basis for medication. For specific medication guidelines, please consult the attending physician.